ContextLogic Inc. (LOGC): A Bull Case Theory
We came across a bullish thesis on ContextLogic Inc. (LOGC) on Substack by TripleS Special Situations. In this article, we will summarize the bulls’ thesis on LOGC. ContextLogic Inc.
Contextlogic Inc. (LOGC)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Schonfeld Strategic Advisors Ryan Tolkin (Cio) | 1,045,626 | $7,350,750 | +7% | 0.04% |
| 2. | AYAL Capital Adir Koschitzky | 827,335 | $5,816,165 | 1.49% | |
| 3. | Steamboat Capital Partners Parsa Kiai | 783,420 | $5,507,443 | -3% | 1.7% |
| 4. | Birnam Oak Advisors Christopher Delong | 778,162 | $5,470,479 | 2.65% | |
| 5. | Solas Capital Management Frederick Tucker Golden | 355,154 | $2,496,733 | +187% | 1.65% |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.64 | 4,369 | 16,701 | 2024-05-16 | Filing | ||
| $5.37 | 9,954 | 29,092 | 2024-05-03 | Filing | ||
| $5.45 | 16,394 | 39,046 | 2024-05-02 | Filing | ||
| $5.41 | 5,720 | 12,450 | 2024-05-03 | Filing | ||
| $5.50 | 500 | 18,170 | 2024-05-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,406 | $16,794 | 0.01% | |
| 2. | 1,713 | $11,956 | 0% | |
| 3. | 556 | $3,881 | 0% | |
| 4. | 391 | $2,729 | 0% | |
| 5. | 4 | $28 | 0% |
News See All
Is LogicBio Therapeutics, Inc. (LOGC) A Good Stock To Buy?
In this article we will analyze whether LogicBio Therapeutics, Inc.
Is LogicBio Therapeutics, Inc. (LOGC) Going to Burn These Hedge Funds?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Hedge Funds Cutting Exposure To LogicBio Therapeutics, Inc. (LOGC)
In this article we will take a look at whether hedge funds think LogicBio Therapeutics, Inc. (NASDAQ:LOGC) is a good investment right now.
Is LogicBio Therapeutics, Inc. (LOGC) A Good Stock To Buy?
"Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much.
Is LogicBio Therapeutics, Inc. (LOGC) A Good Stock To Buy?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Billionaire Hedge Funds
